On May 14, Universal Vision Biotechnology’s board approved the company’s Q1 financial results, reporting a record-high quarterly net income after tax of NT$363 million and earnings per share (EPS) of NT$4.28. Despite a year-over-year decline in gross margin, effective expense control and non-operating income supported this historic performance, reflecting the company’s strong growth momentum.
Revenue for the first quarter reached NT$1.123 billion, representing a 4.86% year-over-year increase. The drop in gross margin—more than two percentage points compared to the same period last year—was mainly attributed to changes in the product mix and fluctuations in certain costs. However, operating profit still rose to NT$393 million, a 6.8% increase, due to disciplined operating expense management. Additionally, the company booked nearly NT$60 million in non-operating gains, primarily from valuation gains on U.S. Treasury investments, further boosting overall profitability.
The company’s performance in Q1 was driven in part by a seasonal rebound in demand for its optical services during the back-to-school period. Expansion efforts also began to yield results. UNIVERSAL VISION plans to open three new stores in Taiwan this year. With the Taoyuan Art & Culture store having officially opened in March, a total of four new locations will contribute to 2025 operations. The company stated that it will maintain an active expansion pace in Taiwan to strengthen its market presence.
In the China market, the company reported a turnaround in the first quarter, ending a streak of five consecutive quarters of losses. This recovery reflects the success of its transformation strategy in the region, which includes closing underperforming stores and reallocating resources to higher-quality locations. The company has also shifted its focus to high-end, self-pay services—offering premium-priced, sophisticated surgical procedures—thus raising average transaction values and injecting new momentum into operations.
Looking ahead, UNIVERSAL VISION noted that while overall market growth has slowed, the outlook for the second half of the year appears more favorable than the first. The company remains optimistic about its full-year performance.
Resource: 大學光本業成長加上業外挹注 首季 EPS 4.28元創單季新高
